TY - JOUR
T1 - Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care
AU - Aljabali, Alaa A.a.
AU - Pal, Kaushik
AU - Serrano-aroca, Angel
AU - Takayama, Kazuo
AU - Dua, Kamal
AU - Tambuwala, Murtaza M.
N1 - © 2021 Elsevier B.V. All rights reserved.
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Early detection is the first step in the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2). Therefore, an efficient, rapid, selective, specific, and inexpensive SARS-CoV-2 diagnostic method is the need of the hour. The reverse transcription-polymerasechain reaction (RT-PCR) technology is massively utilized to detect infection with SARS-CoV-2. However, scientists continue to strive to create enhanced technology while continually developing nanomaterial-enabled biosensing methods that can provide new methodologies, poten-tially fulfilling the present demand for rapid and early identification of coronavirus disease 2019 (COVID-19) patients. Our review presents a summary of the recent diagnosis of SARS-CoV-2 of COVID-19 pandemic and nanomaterial-available biosensing methods. Although limited research on nanomaterials-based nanosensors has been published, allowing for biosensing approaches for diagnosing SARS-CoV-2, this study highlights nano-materials that provide an enhanced biosensing strategy and potential processes that lead to COVID-19 diagnosis
AB - Early detection is the first step in the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2). Therefore, an efficient, rapid, selective, specific, and inexpensive SARS-CoV-2 diagnostic method is the need of the hour. The reverse transcription-polymerasechain reaction (RT-PCR) technology is massively utilized to detect infection with SARS-CoV-2. However, scientists continue to strive to create enhanced technology while continually developing nanomaterial-enabled biosensing methods that can provide new methodologies, poten-tially fulfilling the present demand for rapid and early identification of coronavirus disease 2019 (COVID-19) patients. Our review presents a summary of the recent diagnosis of SARS-CoV-2 of COVID-19 pandemic and nanomaterial-available biosensing methods. Although limited research on nanomaterials-based nanosensors has been published, allowing for biosensing approaches for diagnosing SARS-CoV-2, this study highlights nano-materials that provide an enhanced biosensing strategy and potential processes that lead to COVID-19 diagnosis
KW - SARS-CoV-2
KW - Nanomaterials
KW - Biosensors
KW - Polymerase chain reaction
KW - COVID-19 clinical diagnostics
UR - https://pubmed.ncbi.nlm.nih.gov/34381287/
UR - https://linkinghub.elsevier.com/retrieve/pii/S0167577X21013094
UR - http://www.scopus.com/inward/record.url?scp=85112127550&partnerID=8YFLogxK
U2 - 10.1016/j.matlet.2021.130612
DO - 10.1016/j.matlet.2021.130612
M3 - Article
C2 - 34381287
SN - 0167-577X
VL - 304
JO - Materials Letters
JF - Materials Letters
ER -
